Biotechnology Stocks I Performance Guide: Moderna, Inc. (MRNA)
MRNA has no dividends
Table and Chart of MRNA Performance
See what a $1,000 investment in MRNA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MRNA Returns | |
|---|---|
| Start Date | Jan-31-2019 |
| Start Price | $16.60 |
| End Date | Dec-01-2023 |
| End Price | $79.83 |
| # Prices | 60 |
| Min Date | Jul-31-2019 |
| Min Price | $13.10 |
| Max Date | Sep-30-2021 |
| Max Price | $384.86 |
| Total Return | 380.90% |
| Annualized Return | 36.90% |
| Current Value of $1,000 Purchase | $4,809 |
| Number Returns | 1,770 |
| Average Return | 301.41% |
| Number Profitable Returns | 1,213 |
| Percent Profitable Returns | 68.53% |
| Number Unprofitable Returns | 557 |
| Percent Unprofitable Returns | 31.47% |
| Profitable to Unprofitable Returns Ratio | 2.18 |
| MRNA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $30,441,734,000 | Price to Sales | 3.34 |
| Earnings per Share | $-9.2300 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 2.262 |
| PRICE DATA | |
| 52 Week High | $217.25 |
| 52 Week Low | $62.55 |
| Analyst Target Price | $134.32 |
| 50-Day Moving Average | $84.91 |
| 200-Day Moving Average | $117.68 |
| FINANCIAL DATA | |
| Revenue per Share | $23.78 |
| Revenue | $9,121,000,000 |
| Profit Margin | -38% |
| Return on Equity | -0.22% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MRNA Compare Returns with S&P 500
MRNA Trendline Chart